The Graft

ALL EPISODES AS VIDEO https://youtu.be/La-723RhDIA CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan

FOLLOW MLL Twitter: @leukaemielabor mll.com

FOLLOW Daniela Twitter: @HermelinMD https://www.bloodcenter.org/about/news/authors/daniela-hermelin-md-a7/ https://www.blooducation.com/about-dr-hermelin ALL EPISODES AS AUDIO  APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846   SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab  GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw== CONNECT WITH US https://twitter.com/TheEBMT_Trainee  https://www.ebmt.org/trainee-committee  https://twitter.com/NicoGagelmann  https://twitter.com/Claire_P_Horgan

https://twitter.com/AbbasiMuqtadir  CONNECT WITH US  https://twitter.com/TheEBMT_Trainee   https://www.ebmt.org/trainee-committee   https://twitter.com/NicoGagelmann   https://twitter.com/Claire_P_Horgan

Dr. Brudno researches the use of chimeric antigen receptor (CAR) T-cell  therapy to treat cancers of the blood, including Non-Hodgkin lymphoma,  Hodgkin lymphoma, acute lymphoblastic leukemia (ALL), and multiple  myeloma. Her focus is in the development of phase I clinical trials. She  is also interested in patient safety, particularly in optimizing  patient safety for cellular immunotherapies. Nico Gagelmann and Jennifer Brudno ALL EPISODES AS AUDIO  APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846   SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab  GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw== CONNECT WITH US https://twitter.com/TheEBMT_Trainee  https://www.ebmt.org/trainee-committee  https://twitter.com/NicoGagelmann  https://twitter.com/Claire_P_Horgan

Cindy Chmielewski (@myelomateacher on Twitter) was diagnosed with  multiple myeloma in July 2008 after suffering for two years with  debilitating back pain which was wrongly attributed to degenerative disc  disease. ALL EPISODES AS AUDIO APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846 SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw== CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan CONNECT WITH MYELOMA ADVOCATES https://healthtree.org/myeloma

Heslop is a professor of medicine and pediatrics and holds the Dan L  Duncan Chair at Baylor. She is a physician-scientist engaged in  translational research focusing on adoptive immunotherapy with  gene-modified effector cells to improve hemopoietic stem cell  transplantation and cancer therapy. She has extensive experience in  developing and conducting transplant studies and cell and gene therapy  studies and currently holds more than 20 Investigational New Drug  Applications. She also has played a major role nationally as president  of societies focusing on the intellectual and clinical development of  cellular therapies and accreditation of facilities delivering cell  therapies. Dr. Helen Heslop has been elected to the National Academy of  Medicine. She is among 90 regular members and 10 international members  announced today at the Academy’s annual meeting.

Dr. Mohyuddin completed his medical training at Aga Khan University in  Pakistan and his internal medicine residency at the University of Kansas  where he developed a passion for medical education and treating  hematological malignancies. He completed his fellowship developing a  clinical and research interest in multiple myeloma, drug repurposing,  quality of scientific methods end of life, cost-effective/evidence based  care and medical education. He enjoys the outdoors, and that drew him  to life in Utah where he is currently Assistant Professor at the  Huntsman Cancer Institute with a focus on multiple myeloma.

Nikita Mehra (@DrNikitaMehra) is an Associate Professor at Medical  Oncology and Researcher in Molecular Oncology in the Cancer Institute  (WIA), Chennai, India.

Dr. Raffaella Greco (@RaffaellaGrecoM) is a hematologist in the  Department of Hematology and Bone Marrow Transplantation at the IRCCS  Ospedale San Raffaele under the supervision of Professor Fabio Ciceri. After graduating in 2008 from the Faculty of Medicine and Surgery of the  University of Milan Vita-Salute San Raffaele received a specialization  in hematology at the same university in 2014. CONNECT WITH US  https://twitter.com/TheEBMT_Trainee  https://www.ebmt.org/trainee-committee  https://twitter.com/NicoGagelmann  https://twitter.com/Claire_P_Horgan

Final year hematology fellow: @nihardesai7 Interview: Nico Gagelmann, Claire Horgan CONNECT WITH US  https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan

Anna Sureda is president elect of EBMT

https://www.uicc.org/membership/national-cancer-institute-kiev-ukraine

Assistant Professor, Department of Hematopathology, Division of  Pathology/Lab Medicine, The University of Texas MD Anderson Cancer  Center, Houston, TX Interview: Nico Gagelmann, Claire Horgan

Dr Toby Eyre is a substantive consultant haematologist at Oxford  University Hospitals NHS Foundation Trust specialising in the management  of lymphoid malignancies. He is considered a national expert in the  management of patients with lymphoma and patients with chronic lymphocytic leukaemia. Twitter: https://twitter.com/TobyEyre82 Interview: Nico Gagelmann

Dr. Birhiray earned a Doctor of Medicine degree from the University of  Benin, Nigeria, and completed his Internal Medicine residency at  Columbus Hospital (an affiliate of Northwestern University) in Chicago,  Illinois. He completed fellowships in Bone Marrow Transplant and Medical  Oncology at Johns Hopkins University and The National Cancer Institute  in Bethesda, Maryland, respectively. Dr. Birhiray has participated in  research and is published on the subjects of immunotherapy, lymphomas  and bone marrow transplantation. Dr. Birhiray is a member of The  American Society of Clinical Oncology, American Society of Hematology,  American Medical Association and the Wisconsin Medical Society.  Interview: Nico Gagelmann and Claire Horgan

The following podcast hosts trainees from Latina America, Laura Saavedra  from Venezuela, Andres Gomez from Mexico, Rafaela Muratori from Brazil  and Susy Bazan from Peru. This recording is the second part, where we discuss shared experiences and challenges. But most of the time, we will listen to them and learn from them. The first part with presentations of each country can be found on our youtube channel: https://youtu.be/fJmv5glG1sY

The following is a conversation with Prof Nada Hamad, a senior staff specialist in bone marrow transplant, clinical and laboratory haematologist at St Vincent’s hospital in Sydney, where she is also director of the haematology clinical trials unit. She is President of the Bone Marrow Transplant Society of Australia and New Zealand. She is a senior lecturer at the University of Sydney and University of NSW.

The following is a conversation with Prof Vincent Rajkumar is engaged in  clinical, epidemiological and laboratory research in myeloma and  related disorders. Dr. Rajkumar served as the principal investigator on  several clinical trials for the treatment of myeloma. We talk with him  about myeloma, COVID, how he thinks trainees can make sense of all the  data out there, access to treatments and drug costs. Interview: Nico Gagelmann, Claire Horgan

This conversation is about cancer and all the overwhelming challenges  and potential discrimination that come with the diagnosis, inequalities,  death, the impact of COVID, the importance of time and communication,  and Chris' unique and inspiring story. His website: www.chris-cancercommunity.com SimPal: https://www.yoursimpal.com/ Interview: Nico Gagelmann